Healthcare CMS’ 340B treatment favors hospitals that present much less charity care By / July 24, 2023
Healthcare CMS and outcomes-based pricing for cell and gene remedy – Healthcare Economist By / June 9, 2023
Mental Health CMS: anti-amyloid drug Leqembi (lecanemab) would not meet the “affordable and mandatory” normal required for wider Medicare protection By / March 6, 2023
